[A measure to continue intra-arterial infusion chemotherapy long-term for locally advanced pancreatic cancer]. 1998

H Ohigashi, and O Ishikawa, and H Nakano, and Y Sasaki, and K Murata, and T Yasuda, and M Kameyama, and M Hiratsuka, and T Kabuto, and H Furukawa, and S Imaoka, and A Nakaizumi, and H Uehara, and N Hosomi, and M Fujita, and C Kuroda
Dept. of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases.

For locally advanced non-resectable cancer of the pancreas, we have routinely performed intra-arterial chemotherapy: Each catheter is placed in the splenic artery and gastroduodenal artery during laparotomy, and a mixture of Methotrexate and Angiotensin-II is infused within 30 minutes. This treatment is repeated weekly at our outpatient clinic as long as possible. However, obstruction of the catheter or corresponding artery is the major cause of interruption of treatment. The present paper reports a case in which intra-arterial chemotherapy was possible by repeated catheterization for the catheter obstruction. A 54-year-old woman with non-resectable pancreatic cancer underwent catheter placement during laparotomy, but they became occluded one month later. Another catheter was placed into the common hepatic artery by the Seldinger method. After this catheter was occluded again, another catheter was placed into the inferior pancreaticoduodenal artery via the superior mesenteric artery by the Seldinger method. By repeating this catheter placement, we succeeded in continuing the intra-arterial chemotherapy, and the patient has remained alive (30 postoperative months) without losing her quality of life.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D002408 Catheters, Indwelling Catheters designed to be left within an organ or passage for an extended period of time. Implantable Catheters,In-Dwelling Catheters,Catheter, In-Dwelling,Catheter, Indwelling,Catheters, In-Dwelling,In Dwelling Catheters,In-Dwelling Catheter,Indwelling Catheter,Indwelling Catheters
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

H Ohigashi, and O Ishikawa, and H Nakano, and Y Sasaki, and K Murata, and T Yasuda, and M Kameyama, and M Hiratsuka, and T Kabuto, and H Furukawa, and S Imaoka, and A Nakaizumi, and H Uehara, and N Hosomi, and M Fujita, and C Kuroda
August 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
H Ohigashi, and O Ishikawa, and H Nakano, and Y Sasaki, and K Murata, and T Yasuda, and M Kameyama, and M Hiratsuka, and T Kabuto, and H Furukawa, and S Imaoka, and A Nakaizumi, and H Uehara, and N Hosomi, and M Fujita, and C Kuroda
January 1983, Cancer chemotherapy and pharmacology,
H Ohigashi, and O Ishikawa, and H Nakano, and Y Sasaki, and K Murata, and T Yasuda, and M Kameyama, and M Hiratsuka, and T Kabuto, and H Furukawa, and S Imaoka, and A Nakaizumi, and H Uehara, and N Hosomi, and M Fujita, and C Kuroda
February 1967, The Surgical clinics of North America,
H Ohigashi, and O Ishikawa, and H Nakano, and Y Sasaki, and K Murata, and T Yasuda, and M Kameyama, and M Hiratsuka, and T Kabuto, and H Furukawa, and S Imaoka, and A Nakaizumi, and H Uehara, and N Hosomi, and M Fujita, and C Kuroda
August 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
H Ohigashi, and O Ishikawa, and H Nakano, and Y Sasaki, and K Murata, and T Yasuda, and M Kameyama, and M Hiratsuka, and T Kabuto, and H Furukawa, and S Imaoka, and A Nakaizumi, and H Uehara, and N Hosomi, and M Fujita, and C Kuroda
January 2022, Cancers,
H Ohigashi, and O Ishikawa, and H Nakano, and Y Sasaki, and K Murata, and T Yasuda, and M Kameyama, and M Hiratsuka, and T Kabuto, and H Furukawa, and S Imaoka, and A Nakaizumi, and H Uehara, and N Hosomi, and M Fujita, and C Kuroda
February 1999, Hinyokika kiyo. Acta urologica Japonica,
H Ohigashi, and O Ishikawa, and H Nakano, and Y Sasaki, and K Murata, and T Yasuda, and M Kameyama, and M Hiratsuka, and T Kabuto, and H Furukawa, and S Imaoka, and A Nakaizumi, and H Uehara, and N Hosomi, and M Fujita, and C Kuroda
November 1975, Cancer,
H Ohigashi, and O Ishikawa, and H Nakano, and Y Sasaki, and K Murata, and T Yasuda, and M Kameyama, and M Hiratsuka, and T Kabuto, and H Furukawa, and S Imaoka, and A Nakaizumi, and H Uehara, and N Hosomi, and M Fujita, and C Kuroda
August 1991, Gan to kagaku ryoho. Cancer & chemotherapy,
H Ohigashi, and O Ishikawa, and H Nakano, and Y Sasaki, and K Murata, and T Yasuda, and M Kameyama, and M Hiratsuka, and T Kabuto, and H Furukawa, and S Imaoka, and A Nakaizumi, and H Uehara, and N Hosomi, and M Fujita, and C Kuroda
January 1997, Acta oncologica (Stockholm, Sweden),
H Ohigashi, and O Ishikawa, and H Nakano, and Y Sasaki, and K Murata, and T Yasuda, and M Kameyama, and M Hiratsuka, and T Kabuto, and H Furukawa, and S Imaoka, and A Nakaizumi, and H Uehara, and N Hosomi, and M Fujita, and C Kuroda
August 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!